Home News & Features

News & Features

Doctor holding oxygen ambu bag over patient given oxygen to patient by intubation tube in ICU/Emergency room

ACE inhibitors and Angiotensin Receptor Blockers May Increase Mortality Rate In Elderly COVID-19 Patients

These highly prescribed medications change cell surface protein expression, which is particularly problematic in cells in the respiratory system—tissue that is vulnerable to targeting and attack by the COVID-19 virus.
Source: freestylephoto/Getty Images

20 Molecular Diagnostics Companies to Watch

Up-and-Coming Diagnostic Test Developers Emerge as Consolidation Thins the Field.
corona virus 1

Coronavirus Replication Stopped in 48 Hours in Lab-Grown Cells by Anti-Parasitic Drug

The studies showed that the drug, ivermectin, started to become effective against SARS-CoV-2 in lab-grown cells within just a day and “could essentially remove all viral RNA by 48 hours,” researchers said.
Source: Martin Barraud/Getty Images

10 Countries in 100K Genome Club

These ten governments have committed funding for projects that will sequence a minimum of 100,000 citizens to spur genomic medicine
DNA research concept DNA barcodes for biomedical research  mitochondrial DNA  Prostate cancer DNA test

8 Companion Diagnostic Developers Making a Mark

If companion diagnostics (CDx) were people, they would be old enough to drink. The first CDx won FDA approval in 1998, when Dako Denmark...
Projections for the growth of the liquid biopsy market range as low as $1 billion by 2020

10 Liquid Biopsy Companies in the Money

10 privately-held diagnostics developers primarily focused on liquid biopsy tests, ranked by total money raised from venture capital firms.

Abbott Launching ID NOW COVID-19 Tests, Offering Positive Results in Five Minutes

Company expects to deliver 50,000 tests per day of the rapid, instrument-based, isothermal system designed for qualitative detection of infectious diseases.
Senior male smoking cigarette on black background

Smokers, COPD Patients’ Increased Levels of ACE2 Receptors Make Them More Vulnerable to SARS-CoV-2...

SARS-CoV-2 uses the ACE-2 receptor as a cellular entry receptor, the authors wrote. While the virus can infect people of any age, most of the severe cases, to date, have been in individuals over the age of 55 years and with significant comorbidities, such as COPD.
Old woman with Ventilator mask on Hospital bed

NIH Releases Treatment Guidelines for COVID-19

The guidelines—based on published and preliminary data—are posted online at covid19treatmentguidelines.nih.gov and will be updated regularly as new data from peer-reviewed scientific literature and other authoritative information emerges.
Theme diabetes.the man whose glucose was measured by going to the home of healthcare professionals. It uses the technology of an instrument for measuring the level of glucose in the blood

Diabetic Patients at Higher Risk for COVID-19 Mortality

Mechanisms that may increase COVID-19 susceptibility for diabetics include a higher affinity of cellular binding and efficient virus entry; decreased viral clearance in the blood stream; diminished T cell function; increased susceptibility to hyper-inflammation and cytokine storm syndrome; and the presence of cardiovascular disease.
Scroll Up